Transaction in Own Shares

/**/

RNS Number : 9422V Rolls-Royce Holdings plc 10 March 2026  

10 March 2026   Rolls-Royce Holdings plc Transaction in own shares Rolls-Royce Holdings plc (the "Company" or "Rolls-Royce") announces tody that is has purchased the following number of its ordinary shares of 20 pence each ("Ordinary Shares") through Morgan Stanley & Co. International Plc ("Morgan Stanley") on the London Stock Exchange and other exchanges, as set out below, as part of the £2.3 billion buyback programme announced by the Company on 26 February 2026 (the "Programme"): Date of purchase: 09 March 2026  



London Stock Exchange

CBOE BXE

CBOE CXE

Acquis

Aggregate number of Ordinary Shares purchased:

980,417

630,957

221,811

151,356

Highest price paid per Ordinary Share (p):

1,242.0000

1,241.5000

1,242.0000

1,241.5000

Lowest price paid per Ordinary Share (p):

1,183.5000

1,182.5000

1,182.5000

1,182.5000

Volume weighted average price paid per Ordinary Share (p):

1,220.3400

1,220.1100

1,220.3200

1,222.4400

Rolls-Royce intends to cancel the purchased Ordinary Shares. Following the above transaction, Rolls-Royce does not hold any Ordinary Shares in treasury and has a total of 8,418,554,736 Ordinary Shares in issue. Therefore, the total number of voting rights in the Company will be 8,418,554,736 and this figure may be used by shareholders as the denominator when determining whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. Since the commencement of the Programme, the Company has repurchased 9,281,885 Ordinary Shares in aggregate at a weighted average price of 1294.61 pence per Ordinary Share.   A full breakdown of the individual trades can be found here http://www.rns-pdf.londonstockexchange.com/rns/9422V_1-2026-3-9.pdf This announcement will also be available on Rolls-Royce's website at: https://www.rolls-royce.com/  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  POSVKLFBQXLLBBL